Key result
The Hypertensive Treatment Adherence scale shows strong stability and reliability for evaluating hypertension treatment adherence.
Why the study?
Treatment adherence plays a key role in hypertension management, but a reliable and valid scale to measure adherence was lacking.
Is the Hypertensive Treatment Adherence scale (HTA-scale) a valid and reliable tool for measuring treatment adherence in patients with hypertension?
Cross-Sectional
Is the Hypertensive Treatment Adherence scale (HTA-scale) a valid and reliable tool for measuring treatment adherence in patients with hypertension?
The HTA-scale is a valid and reliable instrument for evaluating treatment adherence in hypertensive patients.
Provides preliminary support for HTA-scale in adherence research; prospective validation required before clinical use.
BACKGROUND: Hypertension (HTN) is a public concern and treatment adherence has a key role in its management. This study was conducted to develop and test the reliability and validity of the Hypertensive Treatment Adherence scale (HTA-scale). METHODS: This was a cross-sectional and methodological study. After item generation using a qualitative study and literature review, the scale was developed. The psychometric properties of the scale were evaluated using face, content, construct, and criterion validity and reliability. RESULTS: Data analysis showed that the HTA-scale had acceptable face and content validity. The scale had excellent stability [Intraclass correlation coefficient (ICC) = 0.74] and good acceptability and internal consistency (Cronbach's a = 0.76). Exploratory factor analysis (EFA) showed that the HTA-scale consisted of 6 meaningful subscales including medication adherence and monitoring, adherence to safe diets, avoiding unsafe diets, self-medication, activity, and smoking. Participants in the controlled blood pressure group had significantly higher HTA-scale scores than the uncontrolled blood pressure group. At the cut-off point of 86, the scale had significant sensitivity and specificity. CONCLUSION: All of the psychometric properties of the HTA-scale achieved the standard level and were sufficient to recommend this scale for patients with HTN.
No takes yet. Share an insight, caveat, or question.
Dehghan et al. (2020) conducted a cross-sectional in Hypertension. Hypertensive Treatment Adherence scale (HTA-scale) was evaluated on Psychometric properties (reliability and validity) of the HTA-scale. The Hypertensive Treatment Adherence scale demonstrated excellent stability (ICC = 0.74) and good internal consistency (Cronbach's a = 0.76) for evaluating treatment adherence in hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: